Skip to Main Content

Current Grants

AbbVie, Inc.
Precision Medicine in Endometriosis: Identification of Progesterone Resistance Using Peripheral Blood Leukocytes
  • P.I. – Dr. Hugh Taylor
  • Awarded – November 2019
Albert McKern Scholar Awards

Pregnancy Outcomes in Women with a Childhood History of Obesity: the Legacy Cohort

  • P.I. – Clare Flannery
  • Awarded July 2023

Role of Hofbauer Cells and Hemoglobin Scavenging in Preeclampsia (PE)

  • P.I. – Seth Guller
  • Awarded July 2023

Understanding the role of health-related stigma and discrimination in the follow-up of women with abnormal cervical cancer screening

  • P.I. - Sangini S. Sheth, MD, MPH
  • Awarded July 2022

The Role of Mesenchymal Progenitor Cells in Abnormal Uterine Repair

  • P.I. - Reshef Tal, MD, PhD
  • Awarded July 2022

The Role of Plasminogen Activator Inhibitors in Endothelial Dysfunction in Preeclampsia

  • P.I. – Dr. Molly McAdow
  • Awarded – July 2021

Mechanism of Decreased Hepatic IGFBP-2 Expression and Gestational Diabetes Mellitus

  • P.I. – Dr. Yingqun Huang
  • Awarded – June 2019
The Blavatnik Family Foundation

De Novo Pyrimidine Synthesis Inhibition for the treatment of ARID1A mutated ovarian cancers and other solid tumors

  • P.I. – Dr. Gloria Huang
  • Awarded – June 2022
Proof of concept efficacy in an in vivo model
  • P.I. – Dr. Yingqun Huang
  • Awarded – June 2023

Buck Institute for Age Research
Determining Molecular Pathways in Human Ovarian Aging
  • P.I. – Na-Young Rho
  • Awarded – June 2023
Burroughs Wellcome Fund

Mechanisms Regulating Fetal Membrane and Neutrophil Responses to Infection

  • P.I. - Dr. Vikki Abrahams
  • Awarded – June 2021
Department of Defense

The Role of TLR7/8-Activating MicroRNAs in Obstetric Antiphospholipid Syndrome

  • P.I. - Dr. Vikki Abrahams
  • Awarded – September 2021
Discovery to Cure

The IMPACT Study: Individualized Precision Combination Therapy Design Using Patient-derived Organoids

  • P.I. – Dr. Gloria Huang
  • Awarded – January 2020
Understanding the Pathogenesis of Childhood Ovarian Cancer
  • P.I. – Dr. Alla Vash-Margita
  • Awarded – August 2022

A potential new therapeutic for ovarian cancer-induced anorexia

  • P.I. – Dr. Yingqun Huang
  • Awarded – August 2022

Abrogation of immune checkpoint and cytokine signaling for tailored treatment of BRCA-associated ovarian cancer

  • P.I. – Dr. Z Ping Lin
  • Awarded – August 2022
Fondazione Guido Berlucchi
CPE Peptide-based Nanoparticles for Ovarian Cancer Detection and Therapy
  • P.I. - Dr. Alessandro Santin
  • Awarded - January 2014
Foundation for Embryonic Competence
Investigation of the Role of Mitochondrial Dynamics in Female Reproduction
  • P.I. - Dr. Emre Seli
  • Awarded - July 2018; July 2019; July 2020; July 2021; and July 2022
John B. Pierce Laboratory

Mechanisms and interventions addressing accelerated cardiovascular disease risk in women with endometriosis

  • P.I. – Dr. Hugh Taylor
  • Awarded – January 2022
Johns Hopkins University
Subaward – Role of Cancer-associated Mutations in Endometriosis
  • P.I. - Dr. Hugh Taylor
  • Awarded – November 2019
NIH/NCI

Uncovering the Mechanisms of Metastasis in Fallopian Tube-Originated Ovarian Cancer

  • P.I. – Dr. Yang Yang-Hartwich
  • Awarded – June 2022
NIH/NICHD

Characterization and prevention of Chemotherapy-Induced Damage to Ovarian Reserve

  • P.I. – Dr. Kutluk Oktay
  • Awarded – April 2022

Uterine Glucocorticoid Signaling: a Critical Pathway in the Establishment of Pregnancy

  • P.I. – Dr. Shannon Whirledge
  • Awarded – March 2021
Steroid Receptor Crosstalk and Pathogenesis of Uterine Fibroids - Diversity Supplemental Grant
  • P.I. – Dr. Shannon Whirledge
  • Awarded – January 2021

Mechanisms of Endometrial Innate Immune Responses to Infection and Impact on Placental Interactions

  • P.I. – Dr. Mancy Tong
  • Awarded – September 2020
Steroid Receptor Crosstalk and Pathogenesis of Uterine Fibroids
  • P.I. – Dr. Shannon Whirledge
  • Awarded – August 2020
Pre-IVF Treatment with a GnRH Antagonist in Women with Endometriosis – A Prospective Double Blind Placebo Controlled Trial (Pregnant)
  • P.I. - Dr. Hugh Taylor
  • Awarded – September 2019
Reproductive Medicine Collaborative Consortium: A Randomized Placebo-controlled Trial of EGCG to Improve Fertility in Women with Uterine Fibroids
  • P.I. - Dr. Hugh Taylor
  • Awarded – September 2019
Obesity-driven Endometrial Hyperplasia in Postmenopausal Women: Synergistic Role for Insulin and Estrone
  • P.I. - Dr. Clare Flannery
  • Awarded - February 2019
The Yale WRHR Career Development Center
  • P.I. - Dr. Hugh Taylor
  • Awarded - July 2015

The Role of Mesenchymal Progenitor Cells in Abnormal Uterine Repair
  • P.I. - Dr. Reshef Tal
  • Awarded – May 2023
NIH/NIDDK
TET3-mediated Epigenetic Regulation of Hepatic Glucose Production
  • P.I. - Dr. Yingqun Huang
  • Awarded – April 2020
R-Pharm US LLC

Santin - R-Pharm US CRA - Whole exome sequencing analysis

  • P.I. – Dr. Alessandro Santin
  • Awarded – March 2023
Paul Titus Fellowship in Obstetrics

Examining 1st trimester maternal exosome levels and miRNA cargo by mode of conception: differential may explain the greater risk of hypertensive disorders in assisted reproductive technology (ART) pregnancies

  • P.I. - Dr. Lubna Pal
  • Awarded - July 2022
Society for Maternal-Fetal Medicine/ American Association of Obstetricians and Gynecologists Foundation (AAOGF)

The Role of Plasminogen Activator Inhibitors in Endothelial Dysfunction in Preeclampsia

  • P.I. – Dr. Molly McAdow
  • Awarded – July 2022
Verastem, Inc.

Verastem RAF/MEK and FAK Inhibitors in Your Endometrioid Models

  • P.I. - Dr. Alessandro Santin
  • Awarded - September 2021
YCCI Fund to Retain Scientists

The Role of Bone Marrow-derived Progenitor Cells in Recurrent Implantation Failure/Pregnancy Loss and Underlying Mechanisms of their Recruitment

  • P.I. – Dr. Reshef Tal
  • Awarded – April 2022